In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa
July 2016
Click for full info +In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa
 | 05 July 2016 |
In this Journal Article:
Health Risk(s):HIV HSV
Product Type(s):Microbicides
Topic(s):Reproductive Health
Full Info:
Resource Type:
Citation:
Villegas, G., Calenda, G., Zhang, S., Mizenina, O., Kleinbeck, K., Cooney, M.L., … Teleshova, N. (2016, July 5). Antimicrobial Agents and Chemotherapy.
Authors:
Villegas, G., Calenda, G., Zhang, S., Mizenina, O., Kleinbeck, K., Cooney, M.L., … Teleshova, N.
Health Risks(s):
- HIV
- HSV
Product type(s):
- Microbicide
Topic(s):
- Reproductive Health
URL of resource:
http://aac.asm.org/content/early/2016/06/28/AAC.00392-16.abstract